OSUR Share Price

Open 8.95 Change Price %
High 9.05 1 Day -0.13 -1.46
Low 8.76 1 Week 0.40 4.78
Close 8.77 1 Month 0.77 9.62
Volume 741369 1 Year 2.49 39.65
52 Week High 9.05
52 Week Low 0.00
OSUR Important Levels
Resistance 2 9.04
Resistance 1 8.93
Pivot 8.86
Support 1 8.61
Support 2 8.50
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

OraSure Technologies, Inc. (NASDAQ: OSUR)

OSUR Technical Analysis 5
As on 9th Dec 2016 OSUR Share Price closed @ 8.77 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.21 & Strong Buy for SHORT-TERM with Stoploss of 8.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
OSUR Target for December
1st Target up-side 9.49
2nd Target up-side 10.24
3rd Target up-side 10.98
1st Target down-side 7.37
2nd Target down-side 6.62
3rd Target down-side 5.88
OSUR Other Details
Segment EQ
Market Capital 502106144.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.orasure.com
OSUR Address
OSUR
220 East First Street
Bethlehem, PA 18015
United States
Phone: 610-882-1820
Fax: 610-882-1830
Interactive Technical Analysis Chart OraSure Technologies, Inc. ( OSUR NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on OraSure Technologies, Inc.
OSUR Business Profile
OraSure Technologies, Inc., is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company's oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The Company's diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory. The Company operates in two segments: OraSure business and DNAG. On August 17, 2011, the Company completed the acquisition of DNA Genotek Inc. (DNAG).